Source comparison
Melanotan-1 Sunless Tanning Complete Guide 2026: Comparison
This table compares Melanotan-1's mechanism, administration, and safety profile against alternative sunless tanning methods and MT-2. Melanotan-1 (MT-1) MC1R agonist. Stimulates eumelanin synthesis via cAMP pathway 10–14 days (implant); 7–10 days (injection) N
This comparison does not assign a generated winner or score.
- This table compares Melanotan-1's mechanism, administration, and safety profile against alternative sunless tanning methods and MT-2.
- Melanotan-1 (MT-1)
- MC1R agonist. Stimulates eumelanin synthesis via cAMP pathway
- 10–14 days (implant); 7–10 days (injection)
- No
- Injection site reaction, mild nausea (<10%), transient flushing
- Gold standard for photoprotective tanning without UV. FDA-approved formulation exists (Scenesse). Selective MC1R binding minimizes systemic effects.
- Melanotan-2 (MT-2)
- Non-selective melanocortin agonist (MC1R, MC3R, MC4R, MC5R)
- 3–5 days
- Nausea (40–60%), spontaneous erections, appetite suppression, blood pressure changes
- Faster onset but significantly higher side effect burden due to MC4R activation. Not FDA-approved for any indication.
- DHA-Based Spray Tans
- Dihydroxyacetone reacts with amino acids in stratum corneum
- 4–6 hours (surface staining)
- Uneven fading, orange cast on palms/soles, contact staining on clothing
- Purely cosmetic. No photoprotection. Stains dead keratinocytes only; wears off in 5–7 days as skin sheds.
- UV Tanning Beds
- Direct DNA damage triggers p53 and POMC release → α-MSH production
- 24–48 hours per session
- Yes (280–400nm UV)
- Erythema, photoaging, 75% increased melanoma risk with use before age 35
- Carcinogenic. IARC Group 1 classification. Tan is a DNA damage response, not a cosmetic benefit.
- Tanning Accelerators (Tyrosine Lotions)
- Topical L-tyrosine supplementation to melanin precursor pool
- Requires concurrent UV exposure; no independent effect
- Yes
- Minimal (topical irritation in sensitive individuals)
- Ineffective without UV. Tyrosine bioavailability through skin is negligible, and melanogenesis is rate-limited by tyrosinase activity, not substrate availability.